Discovery XT consumables

This notice is a Notice of Intent. This notice is published in accordance with Federal Acquisition Regulation (FAR) 5.101(a)(1) requiring dissemination of information regarding proposed contract actions. This is a Notice of Intent to award a Sole Source Firm Fixed Price Contract under the authority of 41 U.S.C. 3304(a)(1), as implemented by FAR 13.106-1(b) - Only One Responsible Source and No Other Supplies or Service Will Satisfy Agency Requirements, and is not a request for competitive quotes.

The National Institute of Allergy and Infectious Diseases (NIAID), Rocky Mountain Laboratories (RML), intends to negotiate on a sole source basis with VENTANA MEDICAL SYSTEMS, INC., 1910 E INNOVATION PARK DR, TUCSON, AZ, 85737-1962 for the procurement of consumables for the Discovery XT. RML requires the following items:

1 DAB Map chromagen stain kit RUO for Discovery XT (760-124) 5266360001  3 each
2 RED Map chromagen stain kit RUO for Discovery XT (760-123) 5266351001  1 each
3 A/B blocker kit, endogenous biotin blocking kit, CE [760-050] 5266092001  2 each
4 bluing reagent 250 tests (760-2037) 5266769001  2 each
5 hematoxylin counterstain 250 tests (760-2021) 5266726001  2 each
6 S block RUO (760-4212) 5268931001  2 each

The North American Industry Classification System (NAICS) code for this procurement is 325413 -In-Vitro Diagnostic Substance Manufacturing with a small business size standard of 1250 employees. Ventana is an "other than small business".

This will be the only notice of the Government's intent to solicit, negotiated, and award to one source to satisfy this requirement. The Government plans to award a contract for this requirement within 5 days of this notice.

While this synopsis does not constitute a solicitation, interested vendors may identify their interest and capability to satisfy this requirement. The Government understands that Ventana is the only vendor which can provide the requested products for NIAID. However, firms that believe they can provide the capability required to fully meet the Government's requirement may submit a capabilities statement, including past performance, in writing to the identified point of contact within five (5) days after publication of this notice. Such documentation shall be evaluated solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. A determination not to compete this requirement, based upon responses to this notice, is solely within the discretion of the Government. Interested parties may identify their interest and capability to respond to the requirement or submit offers on NOI-RML-C-1824818.

For additional information or to submit responses, please contact Peggy Schott at margaret.schott@nih.gov.

Place of Performance:
Rocky Mountain Laboratories
903 South 4th Street
Hamilton, MT 59840
United States